Literature DB >> 30090605

The failure of rodent carcinogenesis as a model for Man.

Colin Berry1.   

Abstract

Recent advances in our understanding of the process of carcinogenesis in Man have required revision of our thinking about the classical initiation/promotion sequence; understanding must now encompass the roles of both genetic and epigenetic change, realisation of the importance of the variable genetic backgrounds of the tumour bearers in any group and an understanding of the importance of random genetic events over time. The behavior of tumours, once established, is more complex than has been thought. Current views of the processes involved are not modelled in toxicity testing programmes.

Entities:  

Year:  2017        PMID: 30090605      PMCID: PMC6062156          DOI: 10.1039/c7tx00283a

Source DB:  PubMed          Journal:  Toxicol Res (Camb)        ISSN: 2045-452X            Impact factor:   3.524


  27 in total

1.  US cancer institute to overhaul tumour cell lines.

Authors:  Heidi Ledford
Journal:  Nature       Date:  2016-02-25       Impact factor: 49.962

2.  Toxicology for the twenty-first century.

Authors:  Thomas Hartung
Journal:  Nature       Date:  2009-07-09       Impact factor: 49.962

3.  Cancer risk: role of environment—response.

Authors:  Cristian Tomasetti; Bert Vogelstein
Journal:  Science       Date:  2015-02-05       Impact factor: 47.728

4.  Hazardous products: Cut animal wastage in toxicology testing.

Authors:  Colin Berry
Journal:  Nature       Date:  2015-07-23       Impact factor: 49.962

5.  Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions.

Authors:  Cristian Tomasetti; Bert Vogelstein
Journal:  Science       Date:  2015-01-02       Impact factor: 47.728

Review 6.  Are lifespan rodent carcinogenicity studies defensible for pharmaceutical agents?

Authors:  A Monro
Journal:  Exp Toxicol Pathol       Date:  1996-02

7.  Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms.

Authors:  Eduard Schulz; Angelika Valentin; Peter Ulz; Christine Beham-Schmid; Karin Lind; Verena Rupp; Herwig Lackner; Albert Wölfler; Armin Zebisch; Werner Olipitz; Jochen Geigl; Andrea Berghold; Michael R Speicher; Heinz Sill
Journal:  J Med Genet       Date:  2012-05-31       Impact factor: 6.318

Review 8.  Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation.

Authors:  Y Katoh; M Katoh
Journal:  Curr Mol Med       Date:  2009-09       Impact factor: 2.222

9.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

10.  Transcription elongation factors represent in vivo cancer dependencies in glioblastoma.

Authors:  Tyler E Miller; Brian B Liau; Lisa C Wallace; Andrew R Morton; Qi Xie; Deobrat Dixit; Daniel C Factor; Leo J Y Kim; James J Morrow; Qiulian Wu; Stephen C Mack; Christopher G Hubert; Shawn M Gillespie; William A Flavahan; Thomas Hoffmann; Rohit Thummalapalli; Michael T Hemann; Patrick J Paddison; Craig M Horbinski; Johannes Zuber; Peter C Scacheri; Bradley E Bernstein; Paul J Tesar; Jeremy N Rich
Journal:  Nature       Date:  2017-07-05       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.